Investor directoryNovartis Venture Fund
The fund focuses on innovative life science companies that address unmet patient needs.
What they invest in
Sectors
Geographies
In numbers
In the last 24 months, Novartis Venture Fund took part in 4 funding rounds on record at Oka. It led or co-led 4 of the 4 rounds where the lead investor was reported. HealthTech is its most frequent sector (4 of 4 rounds with a known sector), Series B its most frequent stage (3 of 4). The most recent round on record is from April 2026.
As of October 2026. Source: Oka, counted from funding rounds reported in the press; rounds that were never reported are not included.
The facts
- Typical cheque
- €5M – €10M
- Headquarters
- Basel, Switzerland
- Founded
- 1996
Portfolio companies
More portfolio companies
and 18 more
Recent rounds
Citryll
€85MSeries BHealthTechForbionleadNovartis Venture FundleadDe Brabantse Ontwikkelings MaatschappijPureos BioventuresBioGeneration VenturesSeventure Partners · +3 more in the source
Netherlandssiliconcanals.com
Rounds Novartis Venture Fund took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- Does Novartis Venture Fund lead rounds?
- Novartis Venture Fund led or co-led 4 of the 4 rounds on record where the lead investor was reported (last 24 months).
- How much does Novartis Venture Fund typically invest?
- Novartis Venture Fund states a typical cheque of €5M – €10M.
- Which stages does Novartis Venture Fund invest in?
- Novartis Venture Fund invests at Seed, Series A, Series B and Growth. In the rounds on record, Series B is the most frequent (3 of 4).
- Where is Novartis Venture Fund based?
- Novartis Venture Fund is headquartered in Basel, Switzerland.
Does Novartis Venture Fund fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Novartis Venture Fund? Tell us what to correct and we will update it — or ask us to remove the entry.